The Company uses a three-level fair value hierarchy that categorizes assets and liabilities measured at fair value based on the observability of the inputs utilized in the valuation. The fair value hierarchy gives the highest priority to the quoted prices in active markets for identical assets and liabilities and lowest priority to unobservable inputs.

•Level 2 – Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable for substantially the full term of the asset or liability.

The Company is exposed to various market risks including, but not limited to, changes in foreign currency exchange rates and market interest rates. The Company manages these risks, in part, through the use of derivative financial instruments. The use of derivative financial instruments creates exposure to credit loss in the event of nonperformance by the counterparty to the derivative financial instruments. The Company limits this exposure by entering into agreements including master netting arrangements directly with a variety of major highly rated financial institutions that are expected to fully satisfy their obligations under the contracts. Additionally, the Company’s ability to utilize derivatives to manage risks is dependent on credit and market conditions. The Company presents its derivative positions and any related material collateral under master netting arrangements that provide for the net settlement of contracts, by counterparty, in the event of default or termination. There is no cash collateral on any of these derivatives.

Derivative financial instruments are measured at fair value on a recurring basis under an income approach using industry-standard models that consider various assumptions, including time value, volatility factors, current market and contractual prices for the underlying, and non-performance risk. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument or may be derived from observable data. Accordingly, the Company's currency instruments are classified as Level 2, "Other Observable Inputs" in the fair value hierarchy.

Cross-Currency Swaps: The Company has executed cross-currency swap transactions intended to mitigate the variability of the U.S. dollar value of its investment in certain of its non-U.S. entities. These swaps are designated as net investment hedges and the Company has elected to assess hedge effectiveness under the spot method. Accordingly, changes in the fair value of the swaps are recorded as a cumulative translation adjustment in AOCI in the Consolidated Balance Sheet.

As of December 31, 2025, the Company had cross-currency swaps with aggregate notional amounts of $200 million intended to mitigate the variability of U.S. dollar value investment in certain of its non-U.S. entities. These swaps are designated as net investment hedges. There was no ineffectiveness associated with such derivatives as of December 31, 2025. The fair value of these derivatives was a non-current liability of $16 million as of December 31, 2025. During the six months ended June 30, 2026, the Company terminated existing cross-currency swaps and paid $13 million upon settlement.

Subsequent to termination, and during the six months ended June 30, 2026, the Company executed cross-currency swap transactions with aggregate notional amounts of $250 million intended to mitigate the variability of U.S. dollar value investment in certain of its non-U.S. entities. These swaps are designated as net investment hedges. There was no ineffectiveness associated with such derivatives as of June 30, 2026. The fair value of these derivatives was a non-current liability of $1 million as of June 30, 2026. As of June 30, 2026, a loss of $3 million is expected to be reclassified out of accumulated other comprehensive income into earnings within the next 12 months.

Interest Rate Swaps: The Company utilizes interest rate swap instruments to manage its exposure and to mitigate the impact of interest rate variability. The swaps are designated as cash flow hedges, accordingly, the effective portion of the changes in fair value is recognized in accumulated other comprehensive income. Subsequently, the accumulated gains and losses recorded in equity are reclassified to income in the period during which the hedged exposure impacts earnings.

As of December 31, 2025, the Company had interest rate swaps with aggregate notional amounts of $250 million. The fair value of these derivatives was a non-current asset of $2 million as of December 31, 2025. During the six months ended June 30, 2026, the Company terminated these interest rate swaps and received $3 million upon settlement.

Subsequent to termination, and during the six months ended June 30, 2026, the Company executed interest rate swaps with aggregate notional amounts of $210 million. The fair value of these derivatives is a non-current asset of less than $1 million as of June 30, 2026. As of June 30, 2026, a gain of approximately less than $1 million is expected to be reclassified out of accumulated other comprehensive income into earnings within the next 12 months.


	Recorded Income (Loss) into AOCI, net of tax				Reclassified from AOCI into Income (Loss)
(In millions)	2026		2025		2026		2025
Three Months Ended June 30,
Interest rate risk - Interest expense, net:
Interest rate swaps	$	(1)	$	(3)	$	—	$	(2)
Net investment hedges	(7)		(7)				—
	$	(8)	$	(10)	$	—	$	(2)
Six Months Ended June 30,
Interest rate risk - Interest expense, net:
Interest rate swaps	$	(2)	$	(8)	$	(1)	$	(5)
Net investment hedges	(5)		(16)		—		—
	$	(7)	$	(24)	$	(1)	$	(5)

The Company's fair value of debt was $302 million and $304 million as of June 30, 2026 and December 31, 2025, respectively. Fair value estimates were based on the current rates offered to the Company for debt of the same remaining maturities. Accordingly, the Company's debt fair value disclosures are classified as Level 2 in the fair value hierarchy.

Financial instruments including cash equivalents, derivative contracts, and accounts receivable, expose the Company to counterparty credit risk for non-performance. The Company’s counterparties for cash equivalents and derivative contracts are banks and financial institutions that meet the Company’s credit rating requirements. The Company’s counterparties for derivative contracts are substantial investment and commercial banks with significant experience using such derivatives. The Company manages its credit risk pursuant to written policies that specify minimum counterparty credit profile and by limiting the concentration of credit exposure amongst its multiple counterparties.